Document Detail


Respiratory distress syndrome: differential effects of prenatal steroid therapy and prolonged rupture of the membranes.
MedLine Citation:
PMID:  1972115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We studied the incidences of respiratory distress syndrome (RDS) and of severe RDS and the survival rate in premature newborns who received a complete prenatal course of betamethasone (N = 49) and in those who did not receive the steroid (N = 546). We also studied the same parameters in steroid-untreated prematures who had prolonged rupture of the membranes (greater than or equal to 24 h, N = 91), and in those who did not (N = 448). We found that the incidences of RDS and severe RDS were significantly lower and the survival rate significantly higher in steroid-treated babies than in untreated babies at 28-32 weeks of gestation (29% vs. 58%, P less than 0.01; 21% vs. 46%, P less than 0.03; and 83% vs. 49%, P less than 0.01, respectively). We also found that untreated babies born after prolonged rupture of the membranes at 28-32 weeks had significantly lower incidences of RDS and severe RDS than untreated babies without prolonged rupture (43% vs. 64%, P less than 0.02; 30% vs. 51% P less than 0.02, respectively). Between 28 and 32 weeks, steroid-treated babies did not have significantly lower incidences of RDS and severe RDS than untreated babies born after prolonged rupture of the membranes (29% vs. 43%, P greater than 0.2; 21% vs. 30%, P greater than 0.3, respectively). The data indicate that between 28 and 32 weeks gestation, the protection against RDS that is provided by prenatal treatment with betamethasone is not superior to that provided by prolonged rupture of the membranes alone.
Authors:
J S Suidan; G Baassiri
Related Documents :
19397605 - Abandoned babies in the uk - a review utilizing media reports.
1083275 - Study of female babies of women entering confinement with vaginal trichomoniasis.
15965625 - Omega-3 for baby and me: material development for a wic intervention to increase dha in...
942225 - Crying vital capacity. measurement of neonatal lung function.
4090975 - Herpes zoster in a 2-week-old premature infant with possible congenital varicella encep...
8509605 - Elder care. a diagnostic model for failure to thrive.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  32     ISSN:  0020-7292     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  1990 Jul 
Date Detail:
Created Date:  1990-07-16     Completed Date:  1990-07-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  237-42     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, American University Medical Center, Beirut, Lebanon.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Betamethasone / administration & dosage,  therapeutic use*
Female
Fetal Membranes, Premature Rupture / complications*
Hospitals, University
Humans
Incidence
Infant Mortality
Infant, Newborn
Injections, Intramuscular
Lebanon
Pregnancy
Prenatal Care
Respiratory Distress Syndrome, Newborn / drug therapy,  epidemiology*,  etiology
Survival Rate
Chemical
Reg. No./Substance:
378-44-9/Betamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perinatal morbidity and mortality in pregnancy hypertensive disorders: prognostic value of the clini...
Next Document:  Plasma zinc and copper in pregnant Nigerian women at term and their newborn babies.